Preview

Problems of Endocrinology

Advanced search

Monogenic diabetes mellitus associated with a mutation in the insulin gene (INS)

https://doi.org/10.14341/probl201359245-48

Abstract

Defects in the insulin gene (INS) are one of the causes responsible for the development of permanent and sometimes transient diabetes mellitus (DM) in the children during the first year of life. Both autosomal dominant and autosomal recessive mutations in the INS gene have been described. Dominant mutations are responsible for the development of absolute insulin deficiency due to precocious apoptosis of pancreatic beta-cells and the formation of the symptomocomplex clinically identical with type 1 diabetes mellitus. Recessive mutations affect insulin biosynthesis and cause DM manifestations within a few first weeks of life of the child. The first case of DM manifestation in a 7-month old girl in Russia is described; it is attributable to a new heterozygous mutation in the insulin gene.

References

1. Aguilar-Bryan L., Bryan J. Neonatal diabetes mellitus. Endocrin Rev 2008; 29: 3: 265-291.

2. Rubio-Cabezas O., Klupa T., Malecki M.T. Permanent neonatal diabetes mellitus - the importance of diabetes differential diagnosis in neonates in infants. Eur J Clin Invest 2011; 41: 3: 323-333.

3. Rubio-Cabezas O., Flanagan S.E., Damhuis A., Hattersley A.T., Ellard S. Monogenic diabetes in infants: time to extend genetic testing beyond the first 6 months of life? Pediatr Diabet 2010; 11: Suppl 14: 17-34.

4. Gabbay K.H., DeLuca K., Fisher J.N., Mako M.E., Rubenstein A.H. Familial hyperproinsulinemia. An autosomal dominant defect. N Engl J Med 1976; 294: 911-915.

5. Barbetti F., Raben N., Kadowaki T., Cama A., Accili D., Gabbay K.H., Merenich J.A., Taylor S.I., Roth J. Two unrelated patients with familial hyperproinsulinemia due to a mutation substituting histidine for arginine at position 65 in the proinsulin molecule: identification of the mutation by direct sequencing of genomic DNA amplified by polymerase chain reaction. J Clin Endocrinol Metabol 1990; 71: 164-169.

6. Stoy J., Edghill E.L., Flanagan S.E., Ye H., Paz V.P., Pluzhnikov A., Below J.E., Hayes M.G., Cox N.J., Lipkind G.M., Lipton R.B., Greeley S.A., Patch A.M., Ellard S., Steiner D.F., Hattersley A.T., Philipson L.H., Bell G.I. Neonatal Diabetes International Collaborative Group. Insulin gene mutations as a cause of permanent neonatal diabetes. Proc Natl Acad Sci USA 2007; 104: 15040-15044.

7. Edghill E.L., Flanagan S.E., Patch A.M., Boustred C., Parrish A., Shields B., Shepherd M.H., Hussain K., Kapoor R.R., Malecki M., MacDonald M.J., Støy J., Steiner D.F., Philipson L.H., Bell G.I., Neonatal Diabetes International Collaborative Group, Hattersley A.T., Ellard S. Insulin mutation screening in 1,044 patients with diabetes: mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood. Diabetes 2008; 57: 1034-1042.

8. Bonfanti R., Colombo C., Nocerino V., Massa O., Lampasona V., Iafusco D., Viscardi M., Chiumello G., Meschi F., Barbetti F. Insulin Gene Mutations as Cause of Diabetes in Children Negative for Five Type 1 Diabetes Autoantibodies. Diabetes Care 2009; 32: 1: 123-125.

9. Molven A., Ringdal M., Nordbø A.M., Raeder H., Støy J., Lipkind G.M., Steiner D.F., Philipson L.H., Bergmann I., Aarskog D., Undlien D.E., Joner G., Søvik O., Norwegian Childhood Diabetes Study Group, Bell G.I., Njølstad P.R. Mutations in the insulin gene can cause MODY and autoantibody-negative type 1 diabetes. Diabetes 2008; 57: 1131-1135.

10. Garin I., Edghill E.L., Akerman I., Rubio-Cabezas O., Rica I., Locke J.M., Maestro M.A., Alshaikh A., Bundak R., del Castillo G., Deeb A., Deiss D., Fernandez J.M., Godbole K., Hussain K., O'Connell M., Klupa T., Kolouskova S., Mohsin F., Perlman K., Sumnik Z., Rial J.M., Ugarte E., Vasanthi T., Neonatal Diabetes International Group, Johnstone K., Flanagan S.E., Martínez R., Castaño C., Patch A.M., Fernández-Rebollo E., Raile K., Morgan N., Harries L.W., Castaño L., Ellard S., Ferrer J., Perez de Nanclares G., Hattersley A.T. Recessive mutations in the INS gene result in neonatal diabetes through reduced insulin biosynthesis. Proc Natl Acad Sci USA 2010; 107: 7: 3105-3110.

11. Colombo C., Porzio O., Liu M., Massa O., Vasta M., Salardi S., Beccaria L., Monciotti C., Toni S., Pedersen O., Hansen T., Federici L., Pesavento R., Cadario F., Federici G., Ghirri P., Arvan P., Iafusco D., Barbetti F. Early Onset Diabetes Study Group of the Italian Society of Pediatric Endocrinology and Diabetes (SIEDP). Seven mutations in the human insulin gene linked to permanent neonatal/infancy-onset diabetes mellitus. J Clin Invest 2008; 118: 6: 2148-2156.

12. Bell G.I., Pictet R.L., Rutter W.J., Cordell B., Tischer E., Goodman H.M. Sequence of the human insulin gene. Nature 1980; 284: 26-32.

13. Støy J., Steiner D.F., Park S.Y., Ye H., Philipson L.H., Bell G.I. Clinical and molecular genetics of neonatal diabetes due to mutations in the insulin gene. Rev Endocrinol Metabol Dis 2010; 11: 3: 205-215.


Review

For citations:


Tikhonovich I.V., Petriaĭkina E.E., Rybkina I.G., Gariaeva I.V., Tiul'pakov A.N. Monogenic diabetes mellitus associated with a mutation in the insulin gene (INS). Problems of Endocrinology. 2013;59(2):45-48. https://doi.org/10.14341/probl201359245-48

Views: 726


ISSN 0375-9660 (Print)
ISSN 2308-1430 (Online)